The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, Guy M., Knopman, David S., Chertkow, Howard, Hyman, Bradley T., Jack, Clifford R., Kawas, Claudia H., Klunk, William E., Koroshetz, Walter J. +10 more·2011·Alzheimer's & Dementia

DOI 10.1016/j.jalz.2011.03.005

Cited by (1,513)

Items 901–1,000 of 1,513

EEG spectral analysis as a putative early prognostic biomarker in nondemented, amyloid positive subjects
Alida A. Gouw, Astrid M. Alsema, Betty Marije Tijms, Andreas Borta, Philip Scheltens, Cornelis Jan Stam, Wiesje M. van der Flier · 2017 · Neurobiology of Aging
Association of Amyloid Positron Emission Tomography With Changes in Diagnosis and Patient Treatment in an Unselected Memory Clinic Cohort
Arno de Wilde, Wiesje M. van der Flier, Wiesje Pelkmans, Femke H. Bouwman, Jurre H. Verwer, Colin Groot, Marieke Meija van Buchem, Marissa Deborah Zwan, Rik Ossenkoppele, Maqsood M. Yaqub et al. · 2018 · JAMA Neurology
Sleep-disordered breathing and the risk of Alzheimer's disease
Claudio Liguori, Michelangelo Maestri, Matteo Spanetta, Fabio Placidi, Enrica Bonanni, Nicola Biagio Mercuri, Biancamaria Guarnieri · 2020 · Sleep Medicine Reviews
Alzheimer's Disease Neurodegenerative Biomarkers Are Associated with Decreased Cognitive Function but Not β-Amyloid in Cognitively Normal Older Individuals
Wirth, Miranka, Madison, Cindee M., Rabinovici, Gil D., Oh, Hwamee, Landau, Susan M., Jagust, William J. · 2013 · The Journal of Neuroscience
Synaptic biomarkers in CSF aid in diagnosis, correlate with cognition and predict progression in MCI and Alzheimer's disease
Galasko, Douglas, Xiao, Meifang, Xu, Desheng, Smirnov, Denis, Salmon, David P., Dewit, Nele, Vanbrabant, Jeroen, Jacobs, Dirk, Vanderstichele, Hugo, Vanmechelen, Eugeen et al. · 2019 · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Parietal Fast Sleep Spindle Density Decrease in Alzheimer’s Disease and Amnesic Mild Cognitive Impairment
Gorgoni, Maurizio, Lauri, Giulia, Truglia, Ilaria, Cordone, Susanna, Sarasso, Simone, Scarpelli, Serena, Mangiaruga, Anastasia, D’Atri, Aurora, Tempesta, Daniela, Ferrara, Michele et al. · 2016 · Neural Plasticity
Self-defining memories during exposure to music in Alzheimer's disease
Mohamad El Haj, Pascal Antoine, Jean‐Louis Nandrino, Marie-Christine Gély-Nargeot, Stéphane Raffard, Henry Brodaty · 2015 · International Psychogeriatrics
Preeclampsia and cognitive impairment later in life
Julie A. Fields, Vesna D. Garovic, Michelle M. Mielke, Kejal Kantarci, Muthuvel Jayachandran, Wendy White, Alissa M. Butts, Jonathan Graff‐Radford, Brian D. Lahr, Kent R. Bailey et al. · 2017 · American Journal of Obstetrics and Gynecology
Electromagnetic signatures of the preclinical and prodromal stages of Alzheimer’s disease
Nakamura, Akinori, Cuesta, Pablo, Fernández, Alberto, Arahata, Yutaka, Iwata, Kaori, Kuratsubo, Izumi, Bundo, Masahiko, Hattori, Hideyuki, Sakurai, Takashi, Fukuda, Koji et al. · 2018 · Brain
Olive oil and prevention of chronic diseases: Summary of an International conference
Francesco Visioli, Manuel Franco, Estefanía Toledo, Jose Alejandro Luchsinger, Walter Churchill Willett, Frank B. Hu, Miguel Ángel Martínez‐González · 2018 · Nutrition Metabolism and Cardiovascular Diseases
Circulating levels of IL-1 family cytokines and receptors in Alzheimer’s disease: new markers of disease progression?
Paola Italiani, Ilaria Puxeddu, Sabrina Napoletano, Emanuele Scala, Daniela Melillo, Simone Manocchio, Antonella Angiolillo, Paola Migliorini, Diana Boraschi, Emilia Vitale et al. · 2018 · Journal of Neuroinflammation
Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid- and 18F-FDG-PET imaging
Ottoy, Julie, Niemantsverdriet, Ellis, Verhaeghe, Jeroen, De Roeck, Ellen, Struyfs, Hanne, Somers, Charisse, wyffels, Leonie, Ceyssens, Sarah, Van Mossevelde, Sara, Van den Bossche, Tobi et al. · 2019 · NeuroImage: Clinical
Pesticides, cognitive functions and dementia: A review
Athina‐Maria Aloizou, Vasileios Siokas, Christina Vogiatzi, Eleni Peristeri, Anca Oana Docea, Demetrios Petrakis, Antonios Provatas, Vasiliki Folia, Charikleia Chalkia, Marco Vinceti et al. · 2020 · Toxicology Letters
Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks: Network-Specificity of AD Pathology
Grothe, Michel J., Teipel, Stefan J., for the Alzheimer's Disease Neuroimaging Initiative · 2016 · Human Brain Mapping
From mild cognitive impairment to subjective cognitive decline: conceptual and methodological evolution.
Cheng, Yu-Wen, Chen, Ta-Fu, Chiu, Ming-Jang · 2017 · Neuropsychiatric Disease and Treatment
Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging
Pittock, Rioghna R., Aakre, Jeremiah A., Castillo, Anna M., Ramanan, Vijay K., Kremers, Walter K., Jack, Clifford R., Vemuri, Prashanthi, Lowe, Val J., Knopman, David S., Petersen, Ronald C. et al. · 2023 · Neurology
Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-sectional Study of Common Conditions in the United States
Ray N Moynihan, Georga Cooke, Jenny A Doust, Lisa Anne Bero, Suzanne Rose Hill, Paul Glasziou · 2013 · PLoS Medicine
Early Alzheimer's Disease Neuropathology Detected by Proton MR Spectroscopy
Melissa Erin Murray, Scott A. Przybelski, Timothy G. Lesnick, Amanda M. Liesinger, Anthony J. Spychalla, Bing Zhang, Jeffrey L. Gunter, Joseph E. Parisi, Bradley F. Boeve, David S. Knopman et al. · 2014 · Journal of Neuroscience
Anxiety Symptoms in Amnestic Mild Cognitive Impairment Are Associated with Medial Temporal Atrophy and Predict Conversion to Alzheimer Disease
Linda Mah, Malcolm A. Binns, David C. Steffens · 2014 · American Journal of Geriatric Psychiatry
Polygenic Overlap Between C-Reactive Protein, Plasma Lipids, and Alzheimer Disease
Desikan, Rahul S., Schork, Andrew J., Wang, Yunpeng, Thompson, Wesley K., Dehghan, Abbas, Ridker, Paul M, Chasman, Daniel I., McEvoy, Linda K., Holland, Dominic, Chen, Chi-Hua et al. · 2015 · Circulation
Can Infections Cause Alzheimer's Disease?
Francis Mawanda, Robert B. Wallace · 2013 · Epidemiologic Reviews
PET Approaches for Diagnosis of Dementia
Kazunari Ishii · 2013 · American Journal of Neuroradiology
Neuropsychological Criteria for Mild Cognitive Impairment and Dementia Risk in the Framingham Heart Study
Amy J. Jak, Sarah R. Preis, Alexa Beiser, Sudha S. Seshadri, Philip A. Wolf, Mark William Bondi, Rhoda Au · 2016 · Journal of the International Neuropsychological Society
Does mild cognitive impairment always lead to dementia? A review
Seema Y. Pandya, Matthew A. Clem, Lynette M. Silva, Fu Lye M. Woon · 2016 · Journal of the Neurological Sciences
Lower cerebral blood flow is associated with impairment in multiple cognitive domains in Alzheimer's disease
Anna Elisabeth Leeuwis, Marije Renske Benedictus, Joost P.A. Kuijer, Maja A. A. Binnewijzend, Astrid M. Hooghiemstra, Sander C.J. Verfaillie, Teddy Koene, Philip Scheltens, Frederik Barkhof, Niels D. Prins et al. · 2016 · Alzheimer s & Dementia
Alzheimer’s disease: How metal ions define β-amyloid function
Kasper P. Kepp · 2017 · Coordination Chemistry Reviews
Diagnostic Accuracy of Memory Measures in Alzheimer’s Dementia and Mild Cognitive Impairment: a Systematic Review and Meta-Analysis
Gali H. Weissberger, Jessica V. Strong, Kayla B. Stefanidis, Mathew James Summers, Mark William Bondi, Nikki H. Stricker · 2017 · Neuropsychology Review
Oligomeric forms of amyloid-β protein in plasma as a potential blood-based biomarker for Alzheimer’s disease
Min Jeong Wang, SangHak Yi, Jee-young Han, Young Ho Park, Jae‐Won Jang, In Kook Chun, Sang Eun Kim, Byoung Sub Lee, Gwang Je Kim, Ji Sun Yu et al. · 2017 · Alzheimer s Research & Therapy
The Role of Biomarkers in Alzheimer’s Disease Drug Development
Jeffrey L. Cummings · 2019 · Advances in experimental medicine and biology
Dysfunctional brain dynamics and their origin in Lewy body dementia
Julia Schumacher, Luis R. Peraza, Michael Firbank, Alan J. Thomas, Marcus Kaiser, Peter Gallagher, John Tiernan O'Brien, Andrew Matthew Blamire, John‐Paul Taylor · 2019 · Brain
Enhanced diagnostic accuracy for neurocognitive disorders: a revised cut-off approach for the Montreal Cognitive Assessment
Alessandra E. Thomann, Manfred Berres, Nicolai Goettel, Luzius A. Steiner, Andreas Urs Monsch · 2020 · Alzheimer s Research & Therapy
Biomarkers for Alzheimer’s Disease Early Diagnosis
Eva Ausó, Violeta Gómez‐Vicente, Gema Esquiva · 2020 · Journal of Personalized Medicine
The Humanistic and Economic Burden of Alzheimer's Disease
Amir Abbas Tahami Monfared, Michael J. Byrnes, Leigh Ann White, Quanwu Zhang · 2022 · Neurology and Therapy
Structural progression of Alzheimer’s disease over decades: the MRI staging scheme
Vincent Planche, José V. Manjón, Boris Mansencal, Enrique Lanuza, Thomas Tourdias, Gwénaëlle Catheline, Pierrick Coupé A · 2022 · Brain Communications
Cognitive and Brain Profiles Associated with Current Neuroimaging Biomarkers of Preclinical Alzheimer's Disease
Besson, F. L., La Joie, R., Doeuvre, L., Gaubert, M., Mezenge, F., Egret, S., Landeau, B., Barre, L., Abbas, A., Ibazizene, M. et al. · 2015 · Journal of Neuroscience
FUNDAMANT: an interventional 72-week phase 1 follow-up study of AADvac1, an active immunotherapy against tau protein pathology in Alzheimer's disease
Novak, Petr, Schmidt, Reinhold, Kontsekova, Eva, Kovacech, Branislav, Smolek, Tomas, Katina, Stanislav, Fialova, Lubica, Prcina, Michal, Parrak, Vojtech, Dal-Bianco, Peter et al. · 2018 · Alzheimer's Research & Therapy
Sleep disturbances and dementia risk: a multicenter study
Sindi, Shireen, Kåreholt, Ingemar, Johansson, Lena, Skoog, Johan, Sjöberg, Linnea, Wang, Hui‐Xin, Johansson, Boo, Fratiglioni, Laura, Soininen, Hilkka, Solomon, Alina et al. · 2018 · Alzheimer's & Dementia
Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review
Blossom C. M. Stephan, Thaı́s Minett, Emma Pagett, Mario Siervo, Carol Brayne, Ian Grant McKeith · 2013 · BMJ Open
Uncovering the Neural Bases of Cognitive and Affective Empathy Deficits in Alzheimer’s Disease and the Behavioral-Variant of Frontotemporal Dementia
Nadene Dermody, Stephanie Wong, Rebekah M. Ahmed, Olivier Piguet, John R. Hodges, Muireann Irish · 2016 · Journal of Alzheimer s Disease
Molecular Mechanisms for Herpes Simplex Virus Type 1 Pathogenesis in Alzheimer’s Disease
Steven A. Harris, Elizabeth A. Harris · 2018 · Frontiers in Aging Neuroscience
Artificial Intelligence for Alzheimer’s Disease: Promise or Challenge?
Carlo Fabrizio, Andrea Termine, Carlo Caltagirone, Giulia Maria Sancesario · 2021 · Diagnostics
Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma
Shephali Bhatnagar, Howard Mark Chertkow, Hyman M. Schipper, Zongfei Yuan, Vikranth Shetty, Samantha F. Jenkins, Timothy William Jones, Eugenia Wang · 2014 · Frontiers in Molecular Neuroscience
Criterion and Convergent Validity of the Montreal Cognitive Assessment with Screening and Standardized Neuropsychological Testing
Benjamin Lam, Laura Elizabeth Middleton, Mario Masellis, Donald T. Stuss, Robin D. Harry, Alex Kiss, Sandra E. Black · 2013 · Journal of the American Geriatrics Society
Multimodality Review of Amyloid-related Diseases of the Central Nervous System
Michelle M. Miller‐Thomas, Adam L. Sipe, Tammie L.S. Benzinger, Jonathan McConathy, Sarah Connolly, Katherine E. Schwetye · 2016 · Radiographics
Mixed dementia: A review of the evidence
Custodio, Nilton, Montesinos, Rosa, Lira, David, Herrera-Pérez, Eder, Bardales, Yadira, Valeriano-Lorenzo, Lucía · 2017 · Dementia & Neuropsychologia
Plasma neurofilament light chain as a biomarker of Alzheimer’s disease in Subjective Cognitive Decline and Mild Cognitive Impairment
Giulia Giacomucci, Salvatore Mazzeo, Silvia Bagnoli, Assunta Ingannato, Deborah Leccese, Valentina Berti, Sonia Padiglioni, Giulia Galdo, Camilla Ferrari, Sandro Sorbi et al. · 2022 · Journal of Neurology
Mesenchymal Stromal Cell Therapies for Neurodegenerative Diseases
Staff, Nathan P., Jones, David T., Singer, Wolfgang · 2019 · Mayo Clinic Proceedings
MicroRNA-29a Is a Candidate Biomarker for Alzheimer’s Disease in Cell-Free Cerebrospinal Fluid
Mareike Müller, Lieke Jäkel, Ilona B. Bruinsma, Jurgen A.H.R. Claassen, H. Bea Kuiperij, Marcel M. Verbeek · 2015 · Molecular Neurobiology
Rapid eye movement sleep disruption and sleep fragmentation are associated with increased orexin-A cerebrospinal-fluid levels in mild cognitive impairment due to Alzheimer's disease
Claudio Liguori, Marzia Nuccetelli, Francesca Izzi, Giuseppe Sancesario, Andrea Romigi, Alessandro Martorana, Chiara Amoroso, Sergio Bernardini, Maria Grazia Marciani, Nicola Biagio Mercuri et al. · 2016 · Neurobiology of Aging
Transcranial direct current stimulation as a memory enhancer in patients with Alzheimer’s disease: a randomized, placebo-controlled trial
Martin K. Bystad, Ole Grønli, Ingrid Daae Rasmussen, Nina Gundersen, Lene Nordvang, Henrik Wang-Iversen, Per Matti Aslaksen · 2016 · Alzheimer s Research & Therapy
Automated Cognitive Health Assessment From Smart Home-Based Behavior Data
Prafulla Dawadi, Diane J. Cook, Maureen Schmitter‐Edgecombe · 2015 · IEEE Journal of Biomedical and Health Informatics
The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer’s Disease
Luise Christine Löwe, Christian Gaser B, Katja Franke, Alzheimer’s Disease Neuroimaging Initiative · 2016 · PLoS ONE
Profile of 6 microRNA in blood plasma distinguish early stage Alzheimer’s disease patients from non-demented subjects
Siranjeevi Nagaraj, Katarzyna Laskowska-Kaszub, Konrad Józef Dębski, Joanna Wojsiat, Michał Dąbrowski, Tomasz Gabryelewicz, Jacek Kuźnicki, Urszula Wojda · 2017 · Oncotarget
Childhood Stress and Adversity is Associated with Late-Life Dementia in Aboriginal Australians
Kylie A. Radford, Kim Delbaere, Brian Draper, Holly A. Mack, Gail Daylight, Robert Graham Cumming, Simon Chalkley, Cecilia Minogue, Gerald Anthony Broe · 2017 · American Journal of Geriatric Psychiatry
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort
Silvia Paola Caminiti, Tommaso Ballarini, Arianna Sala, Chiara Cerami, Luca Presotto, Roberto Santangelo, Federico Fallanca, Emilia Giovanna Vanoli, Luigi Gianolli, Sandro Iannaccone et al. · 2018 · NeuroImage Clinical
The Past and the Future of Alzheimer’s Disease Fluid Biomarkers
Kaj Blennow, Henrik Zetterberg · 2018 · Journal of Alzheimer s Disease
Functional and morphological changes of the retinal vessels in Alzheimer’s disease and mild cognitive impairment
Giuseppe Querques, Enrico Borrelli, Riccardo Sacconi, Luigi Antonio De Vitis, Letizia Leocani, Roberto Santangelo, Giuseppe Magnani, Gıancarlo Comı, Francesco Maria Bandello · 2019 · Scientific Reports
Comparison of serum neurodegenerative biomarkers among hospitalized COVID‐19 patients versus non‐COVID subjects with normal cognition, mild cognitive impairment, or Alzheimer's dementia
Jennifer Ann Frontera, Allal Boutajangout, Arjun V. Masurkar, Rebecca A. Betensky, Yulin Ge, Alok Vedvyas, Ludovic Debure, Andre Moreira, Ariane Lewis, Joshua Huang et al. · 2022 · Alzheimer s & Dementia
Updated appropriate use criteria for amyloid and tau PET: A report from the Alzheimer's Association and Society for Nuclear Medicine and Molecular Imaging Workgroup
Gil Dan Rabinovici, David S. Knopman, Javier Arbizu, Tammie L.S. Benzinger, Kevin J. Donohoe, Oskar Hansson, Peter Herscovitch, Phillip H. Kuo, Jennifer Hagerty Lingler, Satoshi Minoshima et al. · 2025 · Alzheimer s & Dementia
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
Kester, Maartje I., Teunissen, Charlotte E., Sutphen, Courtney, Herries, Elizabeth M., Ladenson, Jack H., Xiong, Chengjie, Scheltens, Philip, van der Flier, Wiesje M., Morris, John C., Holtzman, David M. et al. · 2015 · Alzheimer's Research & Therapy
ADCOMS: a composite clinical outcome for prodromal Alzheimer's disease trials
Wang, Jinping, Logovinsky, Veronika, Hendrix, Suzanne B, Stanworth, Stephanie H, Perdomo, Carlos, Xu, Lu, Dhadda, Shobha, Do, Ira, Rabe, Martin, Luthman, Johan et al. · 2016 · Journal of Neurology, Neurosurgery & Psychiatry
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) study
Yen Ying Lim, Kathryn A. Ellis, Karra Harrington, David J. Ames, Ralph Nigel Martins, Colin Louis Masters, Christopher C. Rowe, Greg R. Savage, Cassandra E. I. Szoeke, David Darby et al. · 2012 · Journal of Clinical and Experimental Neuropsychology
Neuroimaging Biomarkers of Neurodegenerative Diseases and Dementia
Shannon L. Risacher, Andrew J. Saykin · 2013 · Seminars in Neurology
Ushering in the study and treatment of preclinical Alzheimer disease
Jessica B. S. Langbaum, Adam Fleisher, Kewei Chen, Napatkamon Ayutyanont, Francisco Javier Lopera, Yakeel T. Quiroz, Richard J. Caselli, Pierre N. Tariot, Eric M. Reiman · 2013 · Nature Reviews Neurology
Increased plasma levels of BDNF and inflammatory markers in Alzheimer's disease
Mayara Chaves Faria, Gisele Santos Gonçalves, Natália Pessoa Rocha, Edgar Nunes de Moraes, Maria Aparecida Camargos Bicalho, Marco Túlio Gualberto Cintra, Jonas Jardim de Paula, Luís Felipe José Ravic de Miranda, Alessandro Clayton de Souza Ferreira, Antônio Lúcio Teixeira et al. · 2014 · Journal of Psychiatric Research
Brain excitability and connectivity of neuronal assemblies in Alzheimer's disease: From animal models to human findings
Marcello D’Amelio, Paolo Maria Rossini · 2012 · Progress in Neurobiology
Insulin‐like growth factor 2 reverses memory and synaptic deficits in APP transgenic mice
María Pascual‐Lucas, Silvia Viana da Silva, Marianna Di Scala, Carolina García, Gloria González‐Aseguinolaza, Christophe Mulle, Cristina M. Alberini, Mar Cuadrado‐Tejedor, Ana García‐Osta · 2014 · EMBO Molecular Medicine
The role of apolipoprotein E (APOE) genotype in early mild cognitive impairment (E-MCI)
Shannon L. Risacher · 2013 · Frontiers in Aging Neuroscience
Neuropathological diagnoses and clinical correlates in older adults in Brazil: A cross-sectional study
Cláudia Kimie Suemoto, Renata Eloah de Lucena Ferretti‐Rebustini, Roberta Diehl Rodriguez, Renata Elaine Paraízo Leite, Luciana Soterio, Sônia Maria Dozzi Brucki, Raphael Ribeiro Spera, Tarcila Marinho Cippiciani, José M. Farfel, Alexandre Dias Porto Chiavegatto Filho et al. · 2017 · PLoS Medicine
Plasma Amyloid-β (Aβ 42 ) Correlates with Cerebrospinal Fluid Aβ 42 in Alzheimer’s Disease
Charlotte Elisabeth Teunissen, Ming‐Jang Chiu, Che‐Chuan Yang, Shieh‐Yueh Yang, Philip Scheltens, Henrik Zetterberg, Kaj Blennow · 2018 · Journal of Alzheimer s Disease
Imbalance of Circulating Th17 and Regulatory T Cells in Alzheimer’s Disease: A Case Control Study
Timo Jan Oberstein, Lava Taha, Philipp Spitzer, Janina Hellstern, Martin Herrmann i, Johannes Kornhuber, Juan Manuel Maler · 2018 · Frontiers in Immunology
Small Non-coding RNAs: New Class of Biomarkers and Potential Therapeutic Targets in Neurodegenerative Disease
Callum N. Watson, Antonio Belli, Valentina Di Pietro · 2019 · Frontiers in Genetics
Depression, subjective cognitive decline, and the risk of neurocognitive disorders
Tau Ming Liew · 2019 · Alzheimer s Research & Therapy
Validation of the LUMIPULSE automated immunoassay for the measurement of core AD biomarkers in cerebrospinal fluid
Gobom, Johan, Parnetti, Lucilla, Rosa-Neto, Pedro, Vyhnalek, Martin, Gauthier, Serge, Cataldi, Samuela, Lerch, Ondrej, Laczo, Jan, Cechova, Katerina, Clarin, Marcus et al. · 2022 · Clinical Chemistry and Laboratory Medicine (CCLM)
Diagnosis of Alzheimer's Disease Based on Disease-Specific Autoantibody Profiles in Human Sera
Eric P. Nagele, Min Cheol Han, Cassandra A. DeMarshall, Benjamin A. Belinka, Robert G. Nagele · 2011 · PLoS ONE
Cerebrospinal fluid amyloid-β 42/40 ratio in clinical setting of memory centers: a multicentric study
Julien Dumurgier, Susanna Schraen‐Maschke, Audrey Gabelle, Olivier Vercruysse, Stéphanie Bombois, Jean Laplanche, Katell Peoc’h, Bernard Sablonnière, Ksenia V. Kastanenka, Constance Delaby et al. · 2015 · Alzheimer s Research & Therapy
Prevalences of dementia and cognitive impairment among older people in sub-Saharan Africa: a systematic review
Angelique Mavrodaris, john a. powell, Margaret Thorogood · 2013 · Bulletin of the World Health Organization
Early astrocytosis in autosomal dominant Alzheimer’s disease measured in vivo by multi-tracer positron emission tomography
Michael Schöll, Stephen F. Carter, Eric Westman, Elena Rodriguez‐Vieitez, Ove Almkvist, Steinunn Þórðardóttir, Anders E. Wall, Caroline Graff, Bengt Långström, Agneta K. Nordberg · 2015 · Scientific Reports
Diagnostic Accuracy of the Chinese Version of the Trail‐Making Test for Screening Cognitive Impairment
Mingqing Wei, Jing Shi, Ting Li, Jingnian Ni, Xuekai Zhang, Yumeng Li, Shenghua Kang, Fuyun Ma, Hengge Xie, Bin Qin et al. · 2017 · Journal of the American Geriatrics Society
When does cognitive decline begin? A systematic review of change point studies on accelerated decline in cognitive and neurological outcomes preceding mild cognitive impairment, dementia, and death.
Justin E. Karr, Raquel Graham, Scott Michael Hofer, Graciela Muniz Terrera · 2018 · Psychology and Aging
Treatment of dementia and mild cognitive impairment with or without cerebrovascular disease: Expert consensus on the use of Ginkgo biloba extract, EGb 761 ®
Nagaendran Kandiah, Paulus Anam Ong, Yuda Turana, Li‐Ling Ng, Kaysar Mamun, Reshma Aziz Merchant, Christopher Chen, Jacqueline C. Dominguez, S. Marasigan, Encarnita Raya Ampil et al. · 2019 · CNS Neuroscience & Therapeutics
Parafoveal vessel loss and correlation between peripapillary vessel density and cognitive performance in amnestic mild cognitive impairment and early Alzheimer’s Disease on optical coherence tomography angiography
Yi Stephanie Zhang, Nina Zhou, Brianna Knoll, Sahej Samra, Mallory Ward, Sandra Weıntraub, Amani A. Fawzi · 2019 · PLoS ONE
Alzheimer's Disease Detection Through Whole-Brain 3D-CNN MRI
Guilherme Folego, Marina Weiler, Raphael Fernandes Casseb, Ramon Pires, Anderson De Rezende Rocha · 2020 · Frontiers in Bioengineering and Biotechnology
MIND diet and cognitive performance in older adults: a systematic review
Sorayya Kheirouri, Mohammad Alizadeh · 2021 · Critical Reviews in Food Science and Nutrition
Recommendations for cerebrospinal fluid Alzheimer's disease biomarkers in the diagnostic evaluation of mild cognitive impairment
Herukka, Sanna-Kaisa, Simonsen, Anja Hviid, Andreasen, Niels, Baldeiras, Ines, Bjerke, Maria, Blennow, Kaj, Engelborghs, Sebastiaan, Frisoni, Giovanni B., Gabryelewicz, Tomasz, Galluzzi, Samantha et al. · 2017 · Alzheimer's & Dementia
Dominantly Inherited Alzheimer Network: facilitating research and clinical trials
Moulder, Krista L, Snider, B, Mills, Susan L, Buckles, Virginia D, Santacruz, Anna M, Bateman, Randall J, Morris, John C · 2013 · Alzheimer's Research & Therapy
Preliminary Study of Plasma Exosomal Tau as a Potential Biomarker for Chronic Traumatic Encephalopathy
Stern, Robert A., Tripodis, Yorghos, Baugh, Christine M., Fritts, Nathan G., Martin, Brett M., Chaisson, Christine, Cantu, Robert C., Joyce, James A., Shah, Sahil, Ikezu, Tsuneya et al. · 2016 · Journal of Alzheimer’s Disease
The nucleus basalis of Meynert: A new target for deep brain stimulation in dementia?
James Gratwicke, Joshua Kahan, Ludvic U. Zrinzo, Marwan I. Hariz, Patricia Dowsey Limousin, Thomas Foltynie, Marjan Jahanshahi · 2013 · Neuroscience & Biobehavioral Reviews
Diagnosis and biomarkers of predementia in Alzheimer's disease
Orestes Vicente Forlenza, Breno Satler Diniz, Wagner F. Gattaz · 2010 · BMC Medicine
Meta-Review of CSF Core Biomarkers in Alzheimer’s Disease: The State-of-the-Art after the New Revised Diagnostic Criteria
Daniel Ferreira, Lilisbeth Perestelo‐Pérez, Eric Westman, Lars‐Olof Wahlund, Antonio Sarría‐Santamera, Pedro Serrano‐Aguilar · 2014 · Frontiers in Aging Neuroscience
The Epigenetics of Alzheimer’s Disease: Factors and Therapeutic Implications
Xiaolei Liu, Bin Jiao, Lu Hua Shen · 2018 · Frontiers in Genetics
Insights on the pathophysiology of Alzheimer's disease: The crosstalk between amyloid pathology, neuroinflammation and the peripheral immune system
Dá Mesquita, Sandro, Ferreira, Ana Catarina, Sousa, João Carlos, Correia-Neves, Margarida, Sousa, Nuno, Marques, Fernanda · 2016 · Neuroscience & Biobehavioral Reviews
Dissecting the clinical heterogeneity of early-onset Alzheimer’s disease
Sirkis, Daniel W., Bonham, Luke W., Johnson, Taylor P., La Joie, Renaud, Yokoyama, Jennifer S. · 2022 · Molecular Psychiatry
Increased Functional Connectivity in the Default Mode Network in Mild Cognitive Impairment: A Maladaptive Compensatory Mechanism Associated with Poor Semantic Memory Performance
Simona Gardini, Annalena Venneri, Fabio Sambataro, Fernando Cuetos, Fabrizio Fasano, Massimo DE MARCHI, Girolamo Crisi, Paolo Caffarra · 2015 · Journal of Alzheimer s Disease
Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study
Jesse Mez, Todd M. Solomon, Daniel Hamed Daneshvar, Lauren Murphy, Patrick T. Kiernan, Philip H. Montenigro, Joshua Kriegel, Bobak Abdolmohammadi, Brian T. Fry, Katharine J. Babcock et al. · 2015 · Alzheimer s Research & Therapy
Intraneuronal tau aggregation precedes diffuse plaque deposition, but amyloid-β changes occur before increases of tau in cerebrospinal fluid
Heiko Braak, Henrik Zetterberg, Kelly Del Tredici, Kaj Blennow · 2013 · Acta Neuropathologica
Treatment of sleep apnoea syndrome decreases cognitive decline in patients with Alzheimer's disease
Anne‐Cécile Troussière, C. Monaca Charley, Julia Salleron, Florence Richard, Xavier Delbeuck, Philippe Derambure, Florence Pasquier, Stéphanie Bombois · 2014 · Journal of Neurology Neurosurgery & Psychiatry
Cerebrospinal fluid soluble TREM2 in aging and Alzheimer’s disease
Kristi Henjum, Ina S. Almdahl, Vibeke Årskog, Lennart Minthon, Oskar Hansson, Tormod Fladby, Lars N. G. Nilsson · 2016 · Alzheimer s Research & Therapy
Head‐to‐head comparison of clinical performance of CSF phospho‐tau T181 and T217 biomarkers for Alzheimer's disease diagnosis
Karikari, Thomas K., Emeršič, Andreja, Vrillon, Agathe, Lantero‐Rodriguez, Juan, Ashton, Nicholas J., Kramberger, Milica Gregorič, Dumurgier, Julien, Hourregue, Claire, Čučnik, Saša, Brinkmalm, Gunnar et al. · 2021 · Alzheimer's & Dementia
Gender Differences in Alzheimer Disease: Brain Atrophy, Histopathology Burden, and Cognition
Filon, Jessica R., Intorcia, Anthony J., Sue, Lucia I., Vazquez Arreola, Elsa, Wilson, Jeffrey, Davis, Kathryn J., Sabbagh, Marwan N., Belden, Christine M., Caselli, Richard J., Adler, Charles H. et al. · 2016 · Journal of Neuropathology & Experimental Neurology